Owlet (OWLT) Non-Current Deffered Revenue (2020 - 2021)
Owlet (OWLT) reported Non-Current Deffered Revenue of $258000.0 for Q3 2021, down 96.8% year-over-year from $8.0 million in Q3 2020, and down 96.8% quarter-over-quarter from $8.0 million in Q2 2021.
Owlet (OWLT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Owlet (OWLT) has 2 years of Non-Current Deffered Revenue data on file, last reported at $258000.0 in Q3 2021.
- Non-Current Deffered Revenue for Q3 2021 came in at $258000.0, down 96.8% year-over-year; the trailing twelve-month figure through Sep 2021 was $258000.0 (down 96.8% YoY), and the FY2020 annual result was $159000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue eased to $258000.0 in Q3 2021 per OWLT's latest filing, from $8.0 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $8.0 million in Q3 2020 and troughed at $159000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 258,000.00 |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 8.05 Mn |
| Dec 31, 2020 | 159,000.00 |
| Sep 30, 2020 | 8.05 Mn |